8-K: NextTrip and NextTrip Holdings Reach Forbearance Agreement Amid Nasdaq Listing Delays

NextTrip, Inc. and NextTrip Holdings, Inc. have entered into a forbearance agreement due to delays in NextTrip's Nasdaq listing application, impacting the issuance of contingent shares.

Summary

• NextTrip, Inc. and NextTrip Holdings, Inc. have agreed to a forbearance agreement due to delays in NextTrip's Nasdaq listing application.
• The agreement relates to the issuance of contingent shares of NextTrip common stock to NextTrip Holdings, which were to be issued upon achievement of certain milestones.
• NextTrip Holdings believes it has met three of the four milestones, entitling it to 4,350,000 contingent shares.
• However, the issuance of these shares has been delayed due to regulatory issues with NextTrip's S-1 registration statement and Nasdaq listing application.
• The forbearance agreement prevents NextTrip Holdings from issuing a formal notice of milestone achievement until January 31, 2025, or earlier if a default occurs.
• If the Nasdaq listing is not approved by January 31, 2025, NextTrip is obligated to issue the earned contingent shares within five business days and appoint board members within five business days.

Sentiment

Score: 5

Explanation: The document reflects a neutral sentiment. While there are positive aspects such as the structured agreement, the regulatory delays and potential delisting risks create uncertainty.

Positives

• The forbearance agreement provides a structured approach to address the delays in the Nasdaq listing process.
• The agreement ensures that NextTrip Holdings will receive the contingent shares and board appointments if the Nasdaq listing is not approved by the deadline.
• The agreement allows NextTrip to avoid potential delisting issues related to the share issuance.

Negatives

• The delay in the Nasdaq listing process is causing uncertainty and impacting the issuance of contingent shares.
• The regulatory delays are preventing NextTrip Holdings from receiving the shares they have earned.
• The potential for delisting if the shares are issued before Nasdaq approval is a significant risk.

Risks

• The Nasdaq listing application may not be approved by January 31, 2025, triggering the issuance of contingent shares and board appointments.
• The delisting of NextTrip's common stock from Nasdaq is a potential risk if the listing application is not approved.
• The regulatory delays could further impact the company's operations and financial performance.

Future Outlook

The company's future is dependent on the approval of its Nasdaq listing application, which will determine the timing of the contingent share issuance and board appointments. The company will provide updates on the status of the regulatory delays to NextTrip Holdings.

Management Comments

• NextTrip Holdings believes, and the Company does not dispute, that 3 of the 4 milestones have been met.
• NextTrip acknowledges that regulatory delays exist under the Share Exchange Agreement.

Industry Context

This situation highlights the challenges companies face when navigating regulatory hurdles during the listing process. Delays in listing can impact share issuance and overall company strategy.

Stakeholder Impact

• Shareholders of NextTrip face uncertainty due to the potential delisting and the delay in share issuance.
• NextTrip Holdings shareholders are impacted by the delay in receiving their contingent shares.
• Employees may be affected by the uncertainty surrounding the company's listing status.

Next Steps

• NextTrip will continue to work on its Nasdaq listing application.
• NextTrip will provide updates to NextTrip Holdings on the status of the regulatory delays.
• NextTrip will issue the contingent shares and appoint board members if the Nasdaq listing is not approved by January 31, 2025.

Key Dates

Keywords

forbearance agreement, contingent shares, Nasdaq listing, regulatory delays, share issuance, milestones, NextTrip Holdings, NextTrip, Inc.